These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 18941165)

  • 21. Head-to-head comparison of eight late gadolinium-enhanced cardiac MR (LGE CMR) sequences at 1.5 tesla: from bench to bedside.
    Viallon M; Jacquier A; Rotaru C; Delattre BM; Mewton N; Vincent F; Croisille P
    J Magn Reson Imaging; 2011 Dec; 34(6):1374-87. PubMed ID: 21972032
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Optimizing dose and administration regimen of a high-relaxivity contrast agent for myocardial MRI late gadolinium enhancement.
    Secchi F; Di Leo G; Papini GD; Giacomazzi F; Di Donato M; Sardanelli F
    Eur J Radiol; 2011 Oct; 80(1):96-102. PubMed ID: 20638210
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Three-dimensional dynamic susceptibility-weighted perfusion MR imaging at 3.0 T: feasibility and contrast agent dose.
    Manka C; Träber F; Gieseke J; Schild HH; Kuhl CK
    Radiology; 2005 Mar; 234(3):869-77. PubMed ID: 15665227
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Focal liver lesions: SPIO-, gadolinium-, and ferucarbotran-enhanced dynamic T1-weighted and delayed T2-weighted MR imaging in rabbits.
    Schnorr J; Wagner S; Abramjuk C; Drees R; Schink T; Schellenberger EA; Pilgrimm H; Hamm B; Taupitz M
    Radiology; 2006 Jul; 240(1):90-100. PubMed ID: 16684917
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Brain tumor enhancement in magnetic resonance imaging at 3 tesla: intraindividual comparison of two high relaxivity macromolecular contrast media with a standard extracellular gd-chelate in a rat brain tumor model.
    Fries P; Runge VM; Bücker A; Schürholz H; Reith W; Robert P; Jackson C; Lanz T; Schneider G
    Invest Radiol; 2009 Apr; 44(4):200-6. PubMed ID: 19300099
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Brain tumors: full- and half-dose contrast-enhanced MR imaging at 3.0 T compared with 1.5 T--Initial Experience.
    Krautmacher C; Willinek WA; Tschampa HJ; Born M; Träber F; Gieseke J; Textor HJ; Schild HH; Kuhl CK
    Radiology; 2005 Dec; 237(3):1014-9. PubMed ID: 16237142
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intraindividual in vivo comparison of gadolinium contrast agents for pharmacokinetic analysis using dynamic contrast enhanced magnetic resonance imaging.
    Liang J; Sammet S; Yang X; Jia G; Takayama Y; Knopp MV
    Invest Radiol; 2010 May; 45(5):233-44. PubMed ID: 20351653
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Real-time magnetic resonance-guided placement of retrievable inferior vena cava filters: comparison with fluoroscopic guidance with use of in vitro and animal models.
    Shih MC; Rogers WJ; Hagspiel KD
    J Vasc Interv Radiol; 2006 Feb; 17(2 Pt 1):327-33. PubMed ID: 16517779
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Free-breathing high-spatial-resolution delayed contrast-enhanced three-dimensional viability MR imaging of the myocardium at 3.0 T: a feasibility study.
    Amano Y; Matsumura Y; Kumita S
    J Magn Reson Imaging; 2008 Dec; 28(6):1361-7. PubMed ID: 19025943
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Occlusive and reperfused myocardial infarction: detection by using MR imaging with gadolinium polylysine enhancement.
    Lim TH; Lee DH; Kim YH; Park SW; Park PH; Seo DM; Kim ST; Lee TK; Mun CW
    Radiology; 1993 Dec; 189(3):765-8. PubMed ID: 7694313
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Improved detection of subendocardial hyperenhancement in myocardial infarction using dark blood-pool delayed enhancement MRI.
    Farrelly C; Rehwald W; Salerno M; Davarpanah A; Keeling AN; Jacobson JT; Carr JC
    AJR Am J Roentgenol; 2011 Feb; 196(2):339-48. PubMed ID: 21257885
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combined first-pass perfusion and viability study at MR imaging in patients with non-ST segment-elevation acute coronary syndromes: feasibility study.
    Chiu CW; So NM; Lam WW; Chan KY; Sanderson JE
    Radiology; 2003 Mar; 226(3):717-22. PubMed ID: 12601212
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hypertrophic cardiomyopathy: quantification of late gadolinium enhancement with contrast-enhanced cardiovascular MR imaging.
    Harrigan CJ; Peters DC; Gibson CM; Maron BJ; Manning WJ; Maron MS; Appelbaum E
    Radiology; 2011 Jan; 258(1):128-33. PubMed ID: 21045187
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Usefulness of optimized gadolinium-enhanced fast fluid-attenuated inversion recovery MR imaging in revealing lesions of the brain.
    Melhem ER; Bert RJ; Walker RE
    AJR Am J Roentgenol; 1998 Sep; 171(3):803-7. PubMed ID: 9725320
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Acute hyperenhancement on delayed contrast-enhanced magnetic resonance imaging is the characteristic sign after coronary microembolization.
    Ma JY; Qian JY; Jin H; Chen ZW; Chang SF; Yang S; Sun AJ; Zeng MS; Zou YZ; Ge JB
    Chin Med J (Engl); 2009 Mar; 122(6):687-91. PubMed ID: 19323935
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Assessment of the acute effects of glucocorticoid treatment on coronary microembolization using cine, first-pass perfusion, and delayed enhancement MRI.
    Jin H; Yun H; Ma JY; Chen ZW; Chang SF; Ge MY; Zeng MS
    J Magn Reson Imaging; 2016 Apr; 43(4):921-8. PubMed ID: 26361889
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Irreversibly damaged myocardium at MR imaging with a necrotic tissue-specific contrast agent in a cat model.
    Choi SI; Choi SH; Kim ST; Lim KH; Lim CH; Gong GY; Kim HY; Weinmann HJ; Lim TH
    Radiology; 2000 Jun; 215(3):863-8. PubMed ID: 10831712
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Monocyte imaging after myocardial infarction with 19F MRI at 3 T: a pilot study in explanted porcine hearts.
    Bönner F; Merx MW; Klingel K; Begovatz P; Flögel U; Sager M; Temme S; Jacoby C; Salehi Ravesh M; Grapentin C; Schubert R; Bunke J; Roden M; Kelm M; Schrader J
    Eur Heart J Cardiovasc Imaging; 2015 Jun; 16(6):612-20. PubMed ID: 25733209
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Contrast-enhanced echo-planar MR imaging of myocardial perfusion: preliminary study in humans.
    Edelman RR; Li W
    Radiology; 1994 Mar; 190(3):771-7. PubMed ID: 8115626
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular MR imaging of human thrombi in a swine model of pulmonary embolism using a fibrin-specific contrast agent.
    Spuentrup E; Katoh M; Buecker A; Fausten B; Wiethoff AJ; Wildberger JE; Haage P; Parsons EC; Botnar RM; Graham PB; Vettelschoss M; Günther RW
    Invest Radiol; 2007 Aug; 42(8):586-95. PubMed ID: 17620942
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.